{"id":52577,"date":"2026-03-31T15:35:55","date_gmt":"2026-03-31T15:35:55","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/52577\/"},"modified":"2026-03-31T15:35:55","modified_gmt":"2026-03-31T15:35:55","slug":"novo-nordisk-cuts-wegovy-costs-with-subscription-model-for-us-patients","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/52577\/","title":{"rendered":"Novo Nordisk Cuts Wegovy Costs With Subscription Model For US Patients"},"content":{"rendered":"

Novo said patients can save up to $600 per year on Wegovy pills and up to $1,200 per year on Wegovy injections with a 12-month subscription.<\/p>\n

Monthly prices for Wegovy injections range from $329 for three months to $249 for a year-long plan, compared to the usual $349.Comparatively, Eli Lilly’s self-pay pricing for Zepbound starts at $299 per month for the 2.5 mg dose, rising to $399 for 5 mg, and $449 for 7.5 mg.The plan is currently available through telehealth platforms like Ro, WeightWatchers, and LifeMD.<\/p>\n

Novo Nordisk (NVO) has announced a discounted subscription plan for U.S. patients paying out of pocket for its obesity drug Wegovy, in a bid to compete more effectively with Eli Lilly.<\/p>\n

NVO shares<\/a> were little changed in pre-market trading on Tuesday.<\/p>\n

Savings of $600 – $1,200 Annually<\/p>\n

Patients can save up to $600 per year on Wegovy pills and up to $1,200 per year on Wegovy injections with a 12-month subscription, Novo said. The plan, available through telehealth platforms like Ro, WeightWatchers, and LifeMD, allows eligible patients to choose three-, six-, or 12-month subscriptions, with bigger discounts for longer commitments.<\/p>\n

Hims & Hers, Sesame, and other telehealth companies are expected to offer discounts soon.<\/p>\n

\u201cBy providing predictable monthly pricing, multi-month options, and access through trusted telehealth providers, this program aims to support a more manageable way for people to stay on treatment and focus on achieving meaningful, sustainable weight loss outcomes,\u201d said Ed Cinca, senior vice president, Marketing & Patient Solutions at Novo Nordisk.<\/p>\n

Wegovy Pricing Breakdown<\/p>\n

Monthly prices for Wegovy injections range from $329 for three months to $249 for a year-long plan, compared to the usual $349. The pill version is priced between $249 and $289 per month.\u00a0<\/p>\n

Eli Lilly’s self-pay pricing for Zepbound starts at $299 per month for the 2.5 mg dose, rising to $399 for 5 mg, $449 for 7.5 mg, and higher doses.<\/p>\n

This comes just days after Hims and Hers\u00a0launched<\/a> a broad lineup of Novo Nordisk GLP-1 medications on its platform. Novo had earlier dropped its patent infringement lawsuit against Hims related to its blockbuster weight-loss drugs.<\/p>\n

How Did Retail Traders React?<\/p>\n

Retail sentiment on Stocktwits has remained in the \u2018bearish\u2019 territory for a month.<\/p>\n

One user said that until the large institutions change their outlook on Novo, the stock will remain around $35.\u00a0<\/p>\n

Another user said the stock\u2019s valuation is \u201cbeyond cheap.\u201d<\/p>\n

NVO shares have declined by more than 30% so far this year.<\/p>\n

For updates and corrections, email newsroom[at]stocktwits[dot]com.<\/p>\n

\"Follow<\/a><\/p>\n

Subscribe to Chart Art<\/p>\n

Get the daily email that keeps you tuned in and makes markets fun again.<\/p>\n

Read about our editorial guidelines and ethics policy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Novo said patients can save up to $600 per year on Wegovy pills and up to $1,200 per…\n","protected":false},"author":2,"featured_media":10056,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[271],"tags":[29077,7151,272,29075,29076,26297],"class_list":{"0":"post-52577","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-novo-nordisk","8":"tag-eli-lilly-novo-competition","9":"tag-hims-and-hers","10":"tag-novo-nordisk","11":"tag-novo-wegovy-discount","12":"tag-novo-wegovy-injection-discount","13":"tag-us-premarket"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116324531321498417","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/52577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=52577"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/52577\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/10056"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=52577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=52577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=52577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}